Public Health Scotland. (2023) Rapid Action Drug Alerts and Response (RADAR) quarterly report. Edinburgh: Public Health Scotland.
External website: https://www.publichealthscotland.scot/publications...
The Drugs Team at Public Health Scotland (PHS) has compiled this report of drug-related indicators in order to inform action to prevent drug harms and deaths.
The objectives of this report are to:
- monitor changes in drug trends, harms and use of services to inform immediate and short-term actions that reduce drug harms
- detect potential clusters of harms and recommend appropriate responses
- Data and reporting period
Observed changes in indicators may reflect genuine trends in behaviours but may also be influenced by factors such as the configuration of services, or data quality and completeness issues. - This release reports on Scotland-level data. Analysis for some indicators is available by NHS Board in the substance use section of the COVID-19 wider impacts dashboard.
- These data may be subject to change. Further analysis of these data will be made available in our Official and National Statistics publications on substance use.
- Different time periods may be reported across the different indicators. In all cases, the most recently available data are used. Most charts are based upon a 2-year time series.
- Key time periods, during which notable pandemic restrictions were in place, are indicated by reference lines and shaded areas on the charts.
Item Type
Report
Publication Type
International, Open Access, Report
Drug Type
Substances (not alcohol/tobacco), Cocaine, New psychoactive substance
Intervention Type
Harm reduction, Screening / Assessment
Date
31 October 2023
Publisher
Public Health Scotland
Corporate Creators
Public Health Scotland
Place of Publication
Edinburgh
EndNote
Related (external) link
Subjects
B Substances > Sedatives, hypnotics or tranquillisers (CNS depressants)
B Substances > Opioids (opiates) > Opioid product > Naloxone
B Substances > New (novel) psychoactive substances
B Substances > New (novel) psychoactive substances > Benzodiazepines
E Concepts in biomedical areas > Pharmacology and toxicology
G Health and disease > Substance use disorder (addiction) > Multiple substance use (Poly-drug /Poly-substance)
G Health and disease > Substance use disorder (addiction) > Drug use disorder > Drug intoxication > Poisoning (overdose)
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution)
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
J Health care, prevention, harm reduction and treatment > Risk and needs assessment > Risk assessment > Early warning monitoring system
J Health care, prevention, harm reduction and treatment > Identification and screening > Identification and screening for substance use
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control > Needle syringe distribution and exchange
P Demography, epidemiology, and history > Population dynamics > Substance related mortality / death
VA Geographic area > International
VA Geographic area > Europe > United Kingdom > Scotland
B Substances > Opioids (opiates) > Opioid product > Naloxone
B Substances > New (novel) psychoactive substances
B Substances > New (novel) psychoactive substances > Benzodiazepines
E Concepts in biomedical areas > Pharmacology and toxicology
G Health and disease > Substance use disorder (addiction) > Multiple substance use (Poly-drug /Poly-substance)
G Health and disease > Substance use disorder (addiction) > Drug use disorder > Drug intoxication > Poisoning (overdose)
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution)
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
J Health care, prevention, harm reduction and treatment > Risk and needs assessment > Risk assessment > Early warning monitoring system
J Health care, prevention, harm reduction and treatment > Identification and screening > Identification and screening for substance use
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control > Needle syringe distribution and exchange
P Demography, epidemiology, and history > Population dynamics > Substance related mortality / death
VA Geographic area > International
VA Geographic area > Europe > United Kingdom > Scotland
Repository Staff Only: item control page